GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $13,000 | 0.0% | 295 | +1.0% | 0.00% | 0.0% |
| Q1 2022 | $13,000 | 0.0% | 292 | +1.4% | 0.00% | 0.0% |
| Q4 2021 | $13,000 | +18.2% | 288 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $11,000 | 0.0% | 285 | +1.4% | 0.00% | -33.3% |
| Q2 2021 | $11,000 | +10.0% | 281 | +1.4% | 0.00% | 0.0% |
| Q1 2021 | $10,000 | -9.1% | 277 | -5.8% | 0.00% | -25.0% |
| Q4 2020 | $11,000 | 0.0% | 294 | +2.1% | 0.00% | -20.0% |
| Q3 2020 | $11,000 | +10.0% | 288 | +22.0% | 0.01% | 0.0% |
| Q2 2020 | $10,000 | +11.1% | 236 | +1.3% | 0.01% | -16.7% |
| Q1 2020 | $9,000 | -18.2% | 233 | +1.3% | 0.01% | 0.0% |
| Q4 2019 | $11,000 | +10.0% | 230 | +0.9% | 0.01% | -14.3% |
| Q3 2019 | $10,000 | +11.1% | 228 | +1.3% | 0.01% | 0.0% |
| Q2 2019 | $9,000 | 0.0% | 225 | +1.4% | 0.01% | 0.0% |
| Q1 2019 | $9,000 | +12.5% | 222 | +1.4% | 0.01% | 0.0% |
| Q4 2018 | $8,000 | – | 219 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |